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Abstract
Contributions to the multifocal electroretinogram (ERG) from the inner retina (i.e. ganglion and amacrine cells) were identified
by recording from monkeys before and after intravitreal injections of n-methyl DL aspartate (NMDLA) and:or tetrodotoxin
(TTX). Components similar in waveform to those removed by the drugs were identified in the human multifocal ERG if the
stimulus contrast was set at 50% rather than the typically employed 100% contrast. These components were found to be missing
or diminished in the records from some patients with glaucoma and diabetes, diseases which affect the inner retina. © 1999
Elsevier Science Ltd. All rights reserved.
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1. Introduction
The full-field flash electroretinogram (ERG) has had
mixed success for detecting the early signs of retinal
damage caused by glaucoma and diabetes. There are at
least two reasons. Firstly, retinal damage can be re-
stricted to relatively local regions while full-field ERG
techniques record cellular activity averaged over a wide
retinal area. Secondly, damage, especially in the case of
glaucoma, is seen first in the inner retina, where
amacrine and ganglion cells reside, and until recently
these cells have been observed to make relatively small
contributions to the flash ERG. A new technique may
improve the situation. Retinal activity in the form of
focal ERGs can be recorded simultaneously from 100
or more retinal regions employing the multifocal tech-
nique developed by Sutter and his colleagues (Sutter &
Tran, 1992). Furthermore, Sutter and Bearse have re-
ported that ganglion cells contribute to the human
multifocal ERG (Sutter & Bearse, 1995, 1998) and have
provided preliminary indications that glaucomatous
damage can be identified (Bearse, Sutter, Smith &
Stamper, 1995; Bearse, Sutter, Sim & Stamper, 1996).
However, the existence of a ganglion cell contribution
to the human multifocal ERG has been questioned as
also has the effectiveness of the multifocal technique in
detecting changes in patients with glaucoma (Vaegan &
Buckland, 1996; Vaegan & Sanderson, 1997). While
studies of the human multifocal ERG have produced
conflicting results, animal studies have clearly demon-
strated that the inner retina contributes to the multifo-
cal and flash ERG. Tetrodotoxin (TTX), which blocks
all sodium-based action potentials, substantially alters
the multifocal ERG of monkeys (Hood, Frishman,
Viswanathan, Robson & Ahmed, 1999), as well as the
full-field ERG of cats and monkeys (Viswanathan,
Frishman, Robson, Harwerth & Smith, 1996;
Viswanathan & Frishman, 1997). Here we provide evi-
dence that simply reducing the contrast of the display
allows for the detection of inner retinal components in
the human multifocal ERG.
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2. Methods
2.1. Animal
Recordings were made from two adult monkeys
(Macaca mulatta). Experimental and animal care proce-
dures adhered to the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research and were
reviewed by the Institutional Animal Care Committee
of the University of Houston. Pupils were fully dilated
to about 9 mm and the eye to be studied was refracted
retinoscopically and fitted with appropriate contact
lenses. An ophthalmoscopic technique was used to lo-
cate the projection of the fovea on the center of the
stimulus pattern and to determine the position of the
optic disc. Both monkeys received injections of TTX.
One of the monkeys also received injections of NMDLA
and was studied in two sessions. In session one, the
injection of TTX was preceded by injections of
NMDLA. In session two, after 8 weeks of recovery and
when the ERG was back to normal, the TTX injection
was followed by injections of NMDLA. Intravitreal
injections of 40–60 ml were made with a sterile 30 gauge
needle inserted through the pars plana into the vitreal
cavity. Intravitreal concentrations of the pharmacologi-
cal agents were estimated by assuming that the vitreal
volume is 2.1 ml. Recordings were made before and at
least 90 min after injections. For other details see
Frishman, Shen, Du, Robson, Harwerth, Smith,
Carter-Dawson and Crawford (1996) and Hood et al.
(1999).
2.2. Human subjects
Records were obtained from ten normal subjects
(ages 35–64 years, median age of 52 years) and two
patients, one with primary open-angle glaucoma
(POAG) and one with diabetic retinopathy. The patient
with POAG was 38 years of age. The visual acuity in
the tested eye was 20:20, and the cup-to-disk ratio was
0.9. The mean deviation (MD) and corrected pattern
deviations (CPSD) of the Humphrey Field Analyzer
30-2 program were 7.0 and 3.3 dB, respectively. The
patient with moderate nonproliferative diabetic
retinopathy who was 55 years of age, had clinically
significant macular edema. The edema (zone of thicken-
ing) was located approximately 4° temporal to the
fovea and covered a region 5° in diameter. Thus, in
total it covered a small portion, equivalent to less than
four hexagons, of the field stimulated. The visual acuity
in the tested eye was 20:30-2. For all subjects, the pupil
of the tested eye was dilated (1% cyclopentolate hy-
drochloride and 2.5% phenylephrine hydrochloride)
and kept light-adapted at room illumination until the
experiment began. All subjects signed informed consent
forms after the experimental procedures were described
to them. Tenets of the Declaration of Helsinki were
followed and institutional human experimentation com-
mittee approval was obtained.
2.3. Stimulation
The stimulus used to obtain multifocal ERGs has
been described in detail elsewhere (Sutter & Tran, 1992;
Hood, Seiple, Holopigian & Greenstein, 1997). For the
monkey experiments, the stimulus array consisted of
103 equal sized hexagons, each about 3.3° wide, in a
field of about 3533° (see Fig. 1B and Hood et al.
(1999)). For the human experiments, the array con-
sisted of the more typically employed 103 scaled
hexagons in a field of about 4739° (Fig. 3B). In all
cases, the surround region and the space average lumi-
nance were 100 cd m2. The contrast between the
bright and dark hexagons was either 50%, or the maxi-
mum possible, about 88% for the monkey experiments
and about 98% for the human experiments. An experi-
mental run consisted of a m-sequence with 215–1 steps.
The elements of this sequence were 13.33 ms in dura-
tion (corresponding to a screen rate of 75 Hz). How-
ever, the actual duration of the incremental light
producing a white hexagon was about 1 ms. Each run
required about 7 min total recording time, broken into
two equal segments for the monkeys, and 16 segments
for the human subjects. Analyses were based on the
average of two runs. Only first-order responses were
analyzed using the VERIS software from EDI (Electro-
Diagnostic Imaging).
2.4. Recording
For the monkey, ERGs were recorded differentially
between DTL electrodes that were placed under the
corneal contact lenses of both eyes (see Frishman et al.
(1996) for details); one eye was covered. For the human
subjects, ERGs were recorded using Burian–Allen
bipolar, contact lens electrodes (Hood et al., 1997). The
records shown here were recorded with low and high
frequency cut-offs of 10 and 300 Hz for the human
subjects and 1 and 300 Hz for the monkey. Control
recordings demonstrated that the type of electrodes and
cut-off frequencies employed had little effect on the
results.
3. Results
Fig. 1A shows the multifocal responses from one of
the monkeys. As previously reported, the waveform of
the monkeys multifocal ERG varies widely across the
field (Hood et al., 1999). Fig. 1D shows the averaged
responses for groups of hexagons falling at approxi-
mately equal distances from the fovea but different
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Fig. 1. (A) Multifocal records are shown for the control condition for the monkey. The calibration markers indicate 200 nV and 60 ms. (B) The
pattern employed in the multifocal recordings from the macaque. (C) Multifocal records after intravitreal injection of NMDLA (7.7 mM) and TTX
(7.6 mM). The responses are larger in the center because the display (see panel B) has equal size hexagons unlike the display (see Fig. 3B) used
for most of the human experimentation. (D) Responses from panels A and C averaged over the groups shown in panel B. Stimulus contrast was
nearly 100%.
distances from the optic nerve head (ONH) (Sutter &
Bearse, 1995; Hood et al., 1999; Sutter & Bearse, 1998).
The ONH was about 16.5° from the fovea in the
monkey (Cowey, 1967); the closest hexagon to this
location is the one marked with the ‘x’ in Fig. 1B. The
left hand records in Fig. 1D are control responses
averaged over the groups shown in Fig. 1B. With
increasing distance of the hexagons from the ONH, the
response waveform changes from having two positive
peaks to a single peak (see arrows in Fig. 1D). Similar
results are seen for the second monkey in Fig. 2A (first
column).
Inner retinal activity was blocked with intravitreal
injections of NMDLA and:or TTX. TTX blocks
voltage-gated sodium channels and prevents spike gen-
eration in the ganglion cells and their axons as well as
in amacrine cells. NMDLA depolarizes ganglion and at
least some types of amacrine cells (see Massey, 1990;
Massey & Maguire, 1995 for reviews). After treatment
with NMDLA and TTX, the responses appeared to be
smoother (Fig. 1C). The responses from different reti-
nal regions are now essentially identical in shape and
have a single positive peak (see second column in Fig.
1D). Similarly, as previously reported (Hood et al.,
1999), preventing spike generation by injecting only
TTX is sufficient for removing the regional variations
in waveform (see Fig. 2A–second column). The addi-
tion of NMDLA, however, further simplifies the wave-
form. Note for example, the region marked with the
arrow in Fig. 2A after TTX alone, and the change in
that region that occurred when NMDLA was injected
after TTX (Fig. 2B). We have also observed a smooth-
ing of the waveform of the flash ERG after NMDLA in
this monkey as well as in other monkeys (Viswanathan
et al., unpublished observations).
Although variations in response waveforms with reti-
nal location can be seen in the second-order responses
of the human multifocal ERG (Wu & Sutter, 1995),
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Fig. 2. (A) For a second monkey treated with TTX (6.6 mM) alone, responses before and after TTX were averaged over the groups shown in Fig.
1B. (B) For the first monkey 8 weeks after the initial injections, when the ERG had recovery to normal (top), TTX (6.6 mM) was injected first,
and then NMDLA (2.7 mM) was injected. All responses were averaged together. Stimulus contrast was nearly 100%.
previously published first-order responses of the human
multifocal ERGs do not show the wide variations seen
in the monkey’s control records. The dashed curves in
Fig. 3D (first column) show averaged records from a
human subject for a stimulus with the near 100%
contrast that is commonly employed. As in Fig. 1D,
these records are for groups of hexagons falling on
retinal areas that are at approximately equal distances
from the ONH1. The differences in waveforms with
distance from the ONH are subtle. However, on re-ex-
amination of the unpublished data (Hood, Holopigian,
Seiple, Greenstein, Li, Sutter & Carr, 1996), we discov-
ered that waveforms more closely resembling those seen
in the monkey were present in the records from humans
if the stimulus contrast was less than 75%. The solid
curves in Fig. 3D (first column) show the averaged
responses for a stimulus contrast of 50%; the full set of
records is shown in Fig. 3A. With 50% contrast, there
is a qualitative similarity between the records in Fig.
3D and the control records from the monkeys in Fig.
1D and Fig. 2A. The arrows show that when the
stimulus is close to the ONH there are two positive
peaks, while with more remote stimuli, the responses
show a single peak. This qualitative finding has been
replicated in three additional human subjects. Re-
sponses from one of these subjects are included in Fig.
4B (first column).
Glaucomatous damage can produce qualitatively
similar changes to those seen with TTX and NMDLA.
The records from a patient with POAG measured at
50% contrast are shown in Fig. 3C. This patient’s
responses are large, and ‘smoother’ than the responses
from the normal observer in Fig. 3A. Likewise the
waveform of the averaged responses at increasing dis-
tances from the ONH (second column in Fig. 3D) are
more similar to each other than in the case of the
normal observer. (See Bearse et al., 1996 for a similar
observation based upon second-order responses.) Al-
though the records from the control subject show varia-
tion in the extent to which they vary across the field,
none of the ten control subjects have records that
resemble those of the patient in Fig. 3.
Fig. 4A shows records measured at 50% contrast
from the patient with nonproliferative diabetic
retinopathy. Diabetic retinopathy in addition to affect-
ing the outer and mid-retinal layers also affects the
inner retina. In fact, inner retinal changes can occur
before signs of proliferative changes (e.g. Yonemura,
Aoki & Tsuzuki, 1962; Simonsen, 1980). The averaged
responses in Fig. 4B (second column) from this patient,
like the results in the monkey after TTX and NMDLA,
show large, smooth waveforms that are extremely simi-
lar across the retina. Unlike the records from the
patient with glaucoma, however, positive peaks of the
response are slightly delayed. Again, the changes seen
in this patient were not reproduced in any of our ten
controls.
For now, we merely use the patient’s records to
support our claim that the human multifocal ERG has
1 Because of the geometry of the displays it is not possible to obtain
responses that are exactly equidistant from the ONH. Based upon the
visual fields from the human subjects, the OHN probably falls just
below and to the right of the ‘x’ in Fig. 3B.
D.C. Hood et al. : Vision Research 39 (1999) 2285–2291 2289
a sizeable contribution from the inner retina. Before we
can conclude that our findings can be generalized to
other patients, a comprehensive study must be com-
pleted, one in which local ERG changes are compared
with local visual field changes in a patient population
with either glaucomatous damage or diabetic retinopa-
thy. However, based upon a preliminary analysis of
data from a sample of 11 glaucoma patients with field
losses equal to or greater than those for the patient
shown here, we can say that there are other patients
(two in this sample) with dramatic changes that fall
outside our range of normal controls. On the other
hand, there are glaucoma patients with clear field losses
that do not appear to fall outside the normal range, at
least not with the measures thus far devised. With
regard to our findings for the patient with diabetic
retinopathy we have found similar changes in two more
patients with nonproliferative retinopathy and macular
edema. On the other hand, relatively normal responses
were observed in a patient with minimal background
retinopathy.
4. Discussion
The monkey’s multifocal responses vary in waveform
depending upon the retinal region stimulated. Previous
work (Hood et al., 1999), confirmed in the present
study, has shown that these differences in response
waveform are eliminated by TTX, an agent that blocks
sodium-dependent action potentials in ganglion cells,
their axons, and amacrine cells. In other words, it is the
spiking activity of inner retinal neurons that appears to
be the cause of the waveform variations across the
retina. Thus, it seemed important to find conditions
that produce similar location-dependent waveform vari-
ations in humans. When a 50% contrast pattern rather
than a 100% contrast pattern was used, this variation in
waveform could be identified.
Fig. 3. (A) Multifocal records, measured using a stimulus contrast of 50%, are shown for a normal human subject. The calibration markers
indicate 120 nV and 60 ms. (B) The pattern employed in the multifocal recordings for human subjects. (C) As in panel A for the records from
a patient with POAG. (D) The solid curves are the responses from panels A and C averaged over the groups shown in panel B. The dashed lines
are the same group averages for a nearly 100% contrast stimulus.
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Fig. 4. (A) Multifocal records measured using a stimulus contrast of 50% are shown for a patient with diabetic retinopathy. The calibration
markers indicate 120 nV and 60 ms. (B) Responses averaged over the groups are shown in Fig. 3B for a control subject and for the patient whose
records are in panel A.
There are three reasons for believing that there is a
discernible inner retinal contribution to the human
multifocal ERG in response to the 50% contrast stimu-
lus. Firstly, the response waveforms from normal sub-
jects resemble those from the monkey and appear to
have components (see arrows in Fig. 1D and Fig. 3D)
that correspond to those removed by TTX and
NMDLA in the monkey. Secondly, as with the mon-
key’s records, the waveforms vary systematically with
distance from the ONH suggesting that the spiking
activity of the axons of the ganglion cells plays an
important part in shaping the waveforms. And, finally,
the records from the patients with POAG and diabetic
retinopathy (diseases which affect the inner retina) have
two characteristics in common with the records from
the monkey treated with TTX and NMDLA. Firstly,
the waveform of the patient’s responses is approxi-
mately the same across the stimulated retinal areas.
And, secondly, the actual waveforms resemble those
from the treated monkey.
Interestingly, while the patient’s records show a close
resemblance to the records of the treated monkey (Fig.
1C and Fig. 3C), the human control records exhibit
some clear differences when compared to those of the
control monkey (Fig. 1A and Fig. 3A). The differences
are most apparent in the central responses where the
monkey’s records show a greater variation among re-
sponses. Although it is possible that these differences
reflect a relatively larger contribution from the inner
retina in the monkey, an explanation must await a
fuller understanding of the cause of the regional
variations.
Our findings support Sutter and Bearses conclusion
that the multifocal ERG technique can detect local
damage to the inner retina. Sutter and Bearse (1995;
1998) developed an algorithm to extract a component
of the multifocal ERG that they attributed to action
potentials passing through the region of the optic nerve
head. They called this the optic nerve head component
(ONHC) and provided preliminary indications that
glaucomatous damage eliminated it (Bearse et al., 1995,
1996). Recently, Bearse and Sutter (1998) reported that
their ONHC saturates at 60% contrast while the other
components of the multifocal ERG continue to grow
and to dominate the response. This may account for
our finding that a 50% contrast stimulus is superior to
a high contrast stimulus in revealing inner retinal activ-
ity. Increasing the contrast to 100% may also affect the
relative timing of the underlying components (Hood et
al., 1997).
The exact relationship of our findings to Sutter and
Bearse’s ONHC remain to be determined. The patients
records in Fig. 3D and Fig. 4B appear to be more
similar to the monkey’s records after TTX plus
NMDLA than to the monkey’s records after TTX alone
(see Fig. 2 and records in Hood et al. (1999)). NMDLA
depolarizes retinal neurons with NMDA receptors, in
general believed to be both ganglion and at least some
types of amacrine cells (e.g. see reviews of Massey
(1990) and Massey & Maguire (1995)). The post-synap-
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tic currents generated by one or both of these cell
classes seem to be affected in the patients we studied
here.
Previous multifocal studies of patients with diabetes
and glaucoma, using 100% contrast stimuli, have re-
ported more subtle changes compared with those
shown here (Bearse et al., 1995, 1996; Greenstein,
Holopigian, Seiple, Kahanowicz & Katz, 1997; Pal-
mowski, Sutter, Bearse & Fung, 1997). Although it is
likely that relatively larger effects will be seen when
multifocal ERGs are obtained with a 50% contrast
stimulus, whether the multifocal ERGs will prove more
effective than existing techniques in detecting early
diabetic retinopathy and glaucomatous damage remains
to be determined.
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